NCT Heidelberg – Investigator-Initiated Trials (IIT) Forum

Friday 24 Apr 2026, 13:00 → 18:00 Europe/Berlin

Lecture Hall/Kommunikationszentrum (German Cancer Research Center, DKFZ)

 

Hinweis: Vorträge werden in englischer Sprache gehalten. Diskussionen und der Austausch an den Infotischen im Foyer sind selbstverständlich auch auf Deutsch möglich. 
Weitere Informationen finden Sie unten in englischer Sprache.

 

NCT Heidelberg – Investigator-Initiated Trials (IIT) Forum

Funding - Structures - Exchange

On April 24, 2026, NCT Heidelberg invites you to the Investigator-Initiated Trials (IIT) Forum at the DKFZ Communication Center. The event focuses on the Overarching Clinical Translational Trial (OCT²) funding program. It brings together researchers and clinicians from adult and pediatric oncology, along with supporting programs, infrastructures, platforms, and patient representatives, to discuss opportunities for academic clinical trials (IITs) and to foster new collaborations.

Further details on the program can be found below and in the attached poster.

 

 

Registration

Take the opportunity to obtain comprehensive information, discuss practical experiences, and engage in interdisciplinary exchange.

Registration is open until April 23, 2026.

 

 

Meet the Experts

Representatives of key programs, infrastructures, and supporting units will be available for discussions and questions related to academic clinical trials.

Confirmed units include:

• Cancer Information Service (KID)
• Clinical Trial Center (CTC) NCT Heidelberg
• Coordination Centre for Clinical Trials (KKS) Heidelberg
• CTC IT / Digital Oncology Program
• Heidelberg Cell and Liquid Biobank
• Immune Monitoring Unit
• Institute for Medical Biometry (IMBI)
• Institute of Medical Informatics (IMI) (insb. Thema: Digitale Tools zur Erfassung von PROMs)
• Lung Biobank Thoraxklinik
• NCT Sample Processing Laboratory (SPL)
• NCT Tissue Bank
• Patient Research Council NCT Heidelberg
• Section Translational Medical Ethics
• Sponsor Quality Management Unit (SPoQS)

This list is continuously updated.

Further programs, infrastructures, platforms, or supporting units that would like to present their activities are welcome to participate.

Please contact us by April 10, 2026 at: koordination@nct-heidelberg.de

 

 

CME-Accreditation

The event will be submitted for CME accreditation to the Baden-Württemberg Medical Association (Landesärztekammer Baden-Württemberg, LÄK).

 

 

We look forward to welcoming you and to a lively exchange.

ORGANIZER (legally responsible):

German Cancer Research Center (DKFZ) for NCT Heidelberg 

This event is subject to the DKFZ data protection policy.

The NCT Heidelberg is a joint venture of the German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD), Heidelberg University and the Thoraxklinik Heidelberg.

 

HOST

Managing Directorate NCT Heidelberg

 

 

NCT_HD-IIT_Poster_final.pdf

13:00 → 13:30 Registration

13:30 → 13:45 Welcome and introduction

Speaker: Stefan Fröhling

13:45 → 14:15 NCT Overarching Clinical Translational Trial (OCT²) Program: overview, update and support structures

Speakers: Guy Ungerechts, Keno März, Richard Schlenk

14:15 → 14:35 Patient involvement in NCT trials

Speakers: Cindy Körner, Imke Veit-Schirmer, Monika Huber

14:35 → 15:10 OCT² Program: experience reports

• STAR-VACC
• RATIONALE

Speakers: Michael Platten (STAR-VACC), Richard Schlenk (RATIONALE), Stefan Fröhling (RATIONALE)

15:10 → 15:30 Short break

15:30 → 16:00 Education and training opportunities in clinical trials at NCT Heidelberg

Speakers: Stefanie Zschäbitz, Maximilian Schönung

16:00 → 16:30 Pitches: trial-enabling units and posters

16:30 → 18:00 Informal exchange at information booths and posters